Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
OTCQB

ACIXFACARIX AB

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About ACARIX AB (ACIXF)

ACARIX AB (ACIXF) is a Medical Devices company headquartered in Malmo, Sweden whose shares trade over-the-counter on the OTCQB tier.

Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96% certainty.

Products and services

The acoustic technology used in the CADScorSystem enables listening to blood flow in the coronary arteries, sounds that cannot be heard by the human ear. When the arteries are healthy, the blood flow generates a smooth sound. When there is a blockage, stenosis or plaque buildup, the flow is interrupted, then heart murmurs or turbulence can be detected. These heart sounds are picked up by the CADScorSystem and evaluated using integrated algorithms. Our patented algorithm was originally developed at Aalborg University in Denmark to rule out suspected coronary artery disease. Acarix continues to further improve the algorithm and its noise-cancelling properties, resulting in a precise diagnostic aid to safely exclude acoustic agents for coronary artery disease.

ACIXF key facts

Ticker symbol
ACIXF
Market tier
OTCQB
Headquarters
Malmo, Sweden
Country of incorporation
SE
Year of incorporation
2016
Employees
12
Estimated market cap
$24.47M (as of Apr 16, 2025)
Shares outstanding
1,063,743,780
Reporting standard
International Reporting: Nasdaq OMX Nordic Exchange Stockholm
Audit status
Audited
Fiscal year end
12/31
Latest filing
Quarterly Report (Dec 31, 2024)

ACARIX AB leadership

  • Aamir Mahmood — CEO
  • Christian Lindholm — CFO
  • Accounts Payable — Other

Explore more: Medical Devices stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with A

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for ACARIX AB (ACIXF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
Hyllie Boulevard 34 SE- 215 32
Malmo, 21532
Sweden

Company Leadership

Chief Executive Officer

C
CEO Information Not Available
Chief Executive Officer

Company Officers

Aamir Mahmood
CEO
Christian Lindholm
CFO
Accounts Payable
Other

Social Media

Business Details

Stock Details

Loading modules...